14273-46-2

Usage

Uses

Used in Pharmaceutical Drug Development:
5-Pyrimidinemethanamine, 2-methyl(9CI) is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical structure and properties make it a valuable building block for the development of new therapeutic agents with potential applications in treating a wide range of diseases and medical conditions.
Used in Medicinal Chemistry Research:
As a member of the pyrimidine family, 5-Pyrimidinemethanamine, 2-methyl(9CI) is utilized in medicinal chemistry research to explore its potential as a bioactive molecule. Researchers investigate its interactions with biological targets, such as enzymes, receptors, and other proteins, to understand its mechanism of action and identify potential therapeutic applications.
Used in the Study of Biological Processes and Pathways:
5-Pyrimidinemethanamine, 2-methyl(9CI) is employed in the study of various biological processes and pathways to gain insights into its potential role in cellular functions and regulation. By examining its effects on different cellular mechanisms, researchers can better understand its potential implications in health and disease, as well as identify opportunities for its use in therapeutic interventions.

Upstream product

• 2239-83-0 5-(Hydroxymethyl)-2-methylpyrimidine 
• 90905-33-2 2-methyl-5-pyrimidinecarbaldehyde 
• 1073428-44-0 5-(azidomethyl)-2-methylpyrimidine 

Downstream Products

• 1073428-83-7 5-methyl-2-{4-[(2-methyl-pyrimidin-5-ylmethyl)-amino]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl}-benzonitrile 
• 1186518-85-3 3-bromo-N-((2-methylpyrimidin-5-yl)methyl)-5-(pyrrolidine-1-carbonyl)benzamide 
• 1186514-66-8 5-(3-hydroxyazetidine-1-carbonyl)-4'-methyl-N-((2-methylpyrimidin-5-yl)methyl)bipheny-3-carboxamide 
• 1186515-07-0 2,4'-dimethyl-N-((2-methylpyrimidin-5-yl)methyl)-5-(pyrrolidine-1-sulfonyl)biphenyl-3-carboxamide 
• 1217483-90-3 4'-methyl-N-((2-methylpyrimidin-5-yl)methyl)-5-(2-oxopiperidin-1-yl)biphenyl-3-carboxamide 
• 1034257-56-1 1-[4-bromo-2-((3R,5S)-3,5-dimethyl-piperidine-1-carbonyl)-phenyl]-3-(5-methyl-pyrazin-2-ylmethyl)-urea 

Relevant academic research and scientific papers

NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION

The present invention relates to compounds of formula (I), wherein R 1, R2 and R3 are as described herein, and their prodrugs or pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.

AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF

Compounds are provided according to formula (I), where A, B, W, X', L, R1, R3, R4b, and m' are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.

2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof

Fused heterocyclic compounds are provided according to formula 1: where R1, R2, R3, and m are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.